Altium Capital Management LP Nevro Corp Transaction History

Altium Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $437,160 - $592,800	12,000 Added 18.75%	76,000 $3.01 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $1.02 Million - $1.33 Million	-25,000 Reduced 28.09%	64,000 $2.98 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $490,200 - $932,040	12,000 Added 15.58%	89,000 $3.9 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $2.1 Million - $3.22 Million	35,000 Added 83.33%	77,000 $5.57 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $729,629 - $1.09 Million	-9,000 Reduced 17.65%	42,000 $3.41 Million
Q3 2021 Nov 17, 2021	BUY	$101.99 - $166.36 $2.6 Million - $4.24 Million	25,500 Added 100.0%	51,000 $5.94 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $142,786 - $232,904	-1,400 Reduced 5.2%	25,500 $2.87 Million
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $1.56 Million - $1.97 Million	-11,000 Reduced 29.02%	26,900 $4.46 Million
Q1 2021 May 06, 2021	BUY	$132.81 - $182.18 $5.03 Million - $6.9 Million	37,900 New	37,900 $5.29 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.